Date: 08-Aug-2019

GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture

The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSKs Sensodyne, Voltaren and Panadol and Pfizers Advil, Centrum and Caltrate. Underpinned by science-based innovation, it is the global leader in OTC products and has number 1 or 2 market share positions in all key geographies, including the US and China.